XML 21 R71.htm IDEA: XBRL DOCUMENT v2.4.0.6
Deferred Government Grants (Details)
12 Months Ended 0 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2012
USD ($)
item
Dec. 31, 2012
CNY
Dec. 31, 2011
USD ($)
Dec. 31, 2011
CNY
Dec. 31, 2010
USD ($)
Feb. 25, 2013
Beijing Zhongguancun Development Group
CNY
Dec. 31, 2012
Beijing Zhongguancun Development Group
USD ($)
Dec. 31, 2012
Beijing Zhongguancun Development Group
CNY
Dec. 31, 2012
Grants for pandemic influenza vaccine
USD ($)
Dec. 31, 2011
Grants for pandemic influenza vaccine
USD ($)
Dec. 31, 2010
Grants for pandemic influenza vaccine
USD ($)
Dec. 31, 2007
Grants for pandemic influenza vaccine
CNY
Dec. 31, 2012
Grants for pandemic influenza vaccine
CNY
Dec. 31, 2011
Grants for pandemic influenza vaccine
CNY
Dec. 31, 2012
Grants for H1N1
USD ($)
Dec. 31, 2009
Grants for H1N1
CNY
Dec. 31, 2012
Grants for H1N1
CNY
Dec. 31, 2012
Grants for EV 71 vaccine research and development
USD ($)
Dec. 31, 2012
Grants for EV 71 vaccine research and development
CNY
Dec. 31, 2011
Grants for EV 71 vaccine research and development
USD ($)
Dec. 31, 2012
Grant for development of 13-valent pneumococcal conjugate vaccine
USD ($)
Dec. 31, 2012
Grant for development of 13-valent pneumococcal conjugate vaccine
CNY
Classification of deferred government grants                                            
Deferred government grants             $ 216,058   $ 2,037,701 $ 2,277,428     12,695,082 14,495,147 $ 912,238   5,683,333          
Government grants received 936,486 5,908,100 893,149 5,781,800               20,000,000       6,200,000   571,915 3,608,100 433,380 364,570 2,300,000
Number of deferred government grants 2 2                                        
Current Portion 431,097   719,081           288,930       1,800,065   142,167   885,714          
Non- Current Portion 4,068,602   3,388,913           1,748,771       10,895,017   770,071   4,797,619          
Portion of grant recorded as a reduction to depreciation expense                 285,326 278,067 265,547       81,896              
Portion of research and development expense recorded as a reduction in research and development expense 125,222 790,000 686,258   43,278                                  
Interest subsidy received by the entity for Changping facility construction project, recorded as a reduction to interest capitalized 1,458,280 9,200,000 699,776                                      
Loan received $ 16,787,057   $ 11,391,836   $ 19,989,083 6,000,000 $ 963,082 6,000,000                            
Current interest rate (as a percent)             0.36% 0.36%                            
Effective interest rate used to calculate fair value differential (as a percent)             6.90% 6.90%